Global and United States COPD Therapeutics Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bronchodilators
1.2.3 Inhaled Corticosteroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global COPD Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global COPD Therapeutics Market Perspective (2016-2027)
2.2 COPD Therapeutics Growth Trends by Regions
2.2.1 COPD Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COPD Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 COPD Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 COPD Therapeutics Industry Dynamic
2.3.1 COPD Therapeutics Market Trends
2.3.2 COPD Therapeutics Market Drivers
2.3.3 COPD Therapeutics Market Challenges
2.3.4 COPD Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COPD Therapeutics Players by Revenue
3.1.1 Global Top COPD Therapeutics Players by Revenue (2016-2021)
3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COPD Therapeutics Revenue
3.4 Global COPD Therapeutics Market Concentration Ratio
3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2020
3.5 COPD Therapeutics Key Players Head office and Area Served
3.6 Key Players COPD Therapeutics Product Solution and Service
3.7 Date of Enter into COPD Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD Therapeutics Breakdown Data by Type
4.1 Global COPD Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global COPD Therapeutics Forecasted Market Size by Type (2022-2027)
5 COPD Therapeutics Breakdown Data by Application
5.1 Global COPD Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global COPD Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America COPD Therapeutics Market Size (2016-2027)
6.2 North America COPD Therapeutics Market Size by Type
6.2.1 North America COPD Therapeutics Market Size by Type (2016-2021)
6.2.2 North America COPD Therapeutics Market Size by Type (2022-2027)
6.2.3 North America COPD Therapeutics Market Size by Type (2016-2027)
6.3 North America COPD Therapeutics Market Size by Application
6.3.1 North America COPD Therapeutics Market Size by Application (2016-2021)
6.3.2 North America COPD Therapeutics Market Size by Application (2022-2027)
6.3.3 North America COPD Therapeutics Market Size by Application (2016-2027)
6.4 North America COPD Therapeutics Market Size by Country
6.4.1 North America COPD Therapeutics Market Size by Country (2016-2021)
6.4.2 North America COPD Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe COPD Therapeutics Market Size (2016-2027)
7.2 Europe COPD Therapeutics Market Size by Type
7.2.1 Europe COPD Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe COPD Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe COPD Therapeutics Market Size by Type (2016-2027)
7.3 Europe COPD Therapeutics Market Size by Application
7.3.1 Europe COPD Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe COPD Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe COPD Therapeutics Market Size by Application (2016-2027)
7.4 Europe COPD Therapeutics Market Size by Country
7.4.1 Europe COPD Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe COPD Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific COPD Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific COPD Therapeutics Market Size by Type
8.2.1 Asia-Pacific COPD Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COPD Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COPD Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific COPD Therapeutics Market Size by Application
8.3.1 Asia-Pacific COPD Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COPD Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COPD Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific COPD Therapeutics Market Size by Region
8.4.1 Asia-Pacific COPD Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COPD Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America COPD Therapeutics Market Size (2016-2027)
9.2 Latin America COPD Therapeutics Market Size by Type
9.2.1 Latin America COPD Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America COPD Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America COPD Therapeutics Market Size by Type (2016-2027)
9.3 Latin America COPD Therapeutics Market Size by Application
9.3.1 Latin America COPD Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America COPD Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America COPD Therapeutics Market Size by Application (2016-2027)
9.4 Latin America COPD Therapeutics Market Size by Country
9.4.1 Latin America COPD Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America COPD Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COPD Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa COPD Therapeutics Market Size by Type
10.2.1 Middle East & Africa COPD Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COPD Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COPD Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa COPD Therapeutics Market Size by Application
10.3.1 Middle East & Africa COPD Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COPD Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COPD Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa COPD Therapeutics Market Size by Country
10.4.1 Middle East & Africa COPD Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COPD Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Therapeutics Introduction
11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Theravance Biopharma
11.3.1 Theravance Biopharma Company Details
11.3.2 Theravance Biopharma Business Overview
11.3.3 Theravance Biopharma COPD Therapeutics Introduction
11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2016-2021)
11.3.5 Theravance Biopharma Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan COPD Therapeutics Introduction
11.4.4 Mylan Revenue in COPD Therapeutics Business (2016-2021)
11.4.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Inhaled Corticosteroids
Table 4. Key Players of Other
Table 5. Global COPD Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global COPD Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global COPD Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global COPD Therapeutics Market Share by Regions (2016-2021)
Table 9. Global COPD Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global COPD Therapeutics Market Share by Regions (2022-2027)
Table 11. COPD Therapeutics Market Trends
Table 12. COPD Therapeutics Market Drivers
Table 13. COPD Therapeutics Market Challenges
Table 14. COPD Therapeutics Market Restraints
Table 15. Global COPD Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global COPD Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Therapeutics as of 2020)
Table 18. Ranking of Global Top COPD Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COPD Therapeutics Product Solution and Service
Table 22. Date of Enter into COPD Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global COPD Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global COPD Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global COPD Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global COPD Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global COPD Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific COPD Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific COPD Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa COPD Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa COPD Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa COPD Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa COPD Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa COPD Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa COPD Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline COPD Therapeutics Product
Table 65. GlaxoSmithKline Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca COPD Therapeutics Product
Table 70. AstraZeneca Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Theravance Biopharma Company Details
Table 73. Theravance Biopharma Business Overview
Table 74. Theravance Biopharma COPD Therapeutics Product
Table 75. Theravance Biopharma Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Theravance Biopharma Recent Development
Table 77. Mylan Company Details
Table 78. Mylan Business Overview
Table 79. Mylan COPD Therapeutics Product
Table 80. Mylan Revenue in COPD Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of FiguresFigure 1. Global COPD Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Bronchodilators Features
Figure 3. Inhaled Corticosteroids Features
Figure 4. Other Features
Figure 5. Global COPD Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Adult Case Studies
Figure 7. Child Case Studies
Figure 8. COPD Therapeutics Report Years Considered
Figure 9. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global COPD Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global COPD Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global COPD Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global COPD Therapeutics Market Share by Players in 2020
Figure 14. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2020
Figure 16. Global COPD Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global COPD Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America COPD Therapeutics Market Share by Type (2016-2027)
Figure 20. North America COPD Therapeutics Market Share by Application (2016-2027)
Figure 21. North America COPD Therapeutics Market Share by Country (2016-2027)
Figure 22. United States COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe COPD Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe COPD Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe COPD Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific COPD Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific COPD Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific COPD Therapeutics Market Share by Region (2016-2027)
Figure 38. China COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America COPD Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America COPD Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America COPD Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa COPD Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa COPD Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa COPD Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE COPD Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 59. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in COPD Therapeutics Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed